Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer (Q73923952)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Müller W

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Schneiders A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Heider KH

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Meier S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Hommel G

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Gabbert HE

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

222-227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390037%20AND%20SRC:MED&resulttype=core&format=json

CD44 is the principal cell surface receptor for hyaluronate

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Expression of CD44 confers a new adhesive phenotype on transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

CD44 variant exon epitopes in primary breast cancer and length of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Expression of CD44 and Its Clinical Implication in Diffuse–Type and Intestinal–Type Gastric Adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

De-novo expression of CD44 and survival in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Prevention of tumor metastasis formation by anti-variant CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Significance of CD44 gene products for cancer diagnosis and disease evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Effect of CD44v6 on survival in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C222%3A%3AAID-PATH923%3E3.0.CO%3B2-C

10.1002/(SICI)1096-9896(199710)183:2<222::AID-PATH923>3.0.CO;2-C

21 January 2018

Identifiers

DOI

0 references

1 reference